110 related articles for article (PubMed ID: 15498719)
1. Safety and efficacy in retrovirally modified haematopoietic cell therapy.
Li Z; Modlich U; Baum C
Best Pract Res Clin Haematol; 2004 Sep; 17(3):493-503. PubMed ID: 15498719
[TBL] [Abstract][Full Text] [Related]
2. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
Kang EM; Tisdale JF
Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
[TBL] [Abstract][Full Text] [Related]
3. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
Neschadim A; McCart JA; Keating A; Medin JA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of retroviral integration in hematopoietic cells.
Nienhuis AW; Dunbar CE; Sorrentino BP
Mol Ther; 2006 Jun; 13(6):1031-49. PubMed ID: 16624621
[TBL] [Abstract][Full Text] [Related]
5. [Prospects for gene therapy in hematology].
Moreau-Gaudry F; Mazurier F; Salesse S; Fontanellas A; Verneuil HD
Ann Biol Clin (Paris); 1999; 57(1):43-50. PubMed ID: 9920966
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell gene therapy: progress toward therapeutic targets.
Vollweiler JL; Zielske SP; Reese JS; Gerson SL
Bone Marrow Transplant; 2003 Jul; 32(1):1-7. PubMed ID: 12815471
[TBL] [Abstract][Full Text] [Related]
7. Progress towards hematopoietic stem cell gene therapy.
Kurre P; Kiem HP
Curr Opin Mol Ther; 2000 Aug; 2(4):400-11. PubMed ID: 11249770
[TBL] [Abstract][Full Text] [Related]
8. Genetic manipulation of drug sensitivity in haematopoietic cells.
Southgate T; Fairbairn LJ
Expert Rev Mol Med; 2004 Aug; 6(18):1-24. PubMed ID: 15387894
[TBL] [Abstract][Full Text] [Related]
9. Alternative viral envelopes for oncoretroviruses to increase gene transfer into hematopoietic stem cells.
Barrette S; Orlic D
Curr Opin Mol Ther; 2000 Oct; 2(5):507-14. PubMed ID: 11249753
[TBL] [Abstract][Full Text] [Related]
10. Instant conditional transgenesis in the mouse hematopoietic compartment.
Csikós T; Reijmers RM; Uren AG; Spaargaren M; Pals ST
J Immunol Methods; 2008 Dec; 339(2):259-63. PubMed ID: 18793641
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for the hemoglobin disorders.
Persons DA; Nienhuis AW
Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333
[TBL] [Abstract][Full Text] [Related]
12. Decreased homing of retrovirally transduced human bone marrow CD34+ cells in the NOD/SCID mouse model.
Hall KM; Horvath TL; Abonour R; Cornetta K; Srour EF
Exp Hematol; 2006 Apr; 34(4):433-42. PubMed ID: 16569590
[TBL] [Abstract][Full Text] [Related]
13. Efficient engraftment of in utero transplanted mice with retrovirally transduced hematopoietic stem cells.
Rio P; Martinez-Palacio J; Ramirez A; Bueren JA; Segovia JC
Gene Ther; 2005 Feb; 12(4):358-63. PubMed ID: 15550924
[TBL] [Abstract][Full Text] [Related]
14. Is retroviral gene marking too dangerous to use?
Brenner MK; Heslop HE
Cytotherapy; 2003; 5(3):190-3. PubMed ID: 12850996
[No Abstract] [Full Text] [Related]
15. Progress toward the genetic treatment of the beta-thalassemias.
Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
[TBL] [Abstract][Full Text] [Related]
16. Towards hematopoietic stem cell-mediated protection against infection with human immunodeficiency virus.
Schambach A; Schiedlmeier B; Kühlcke K; Verstegen M; Margison GP; Li Z; Kamino K; Bohne J; Alexandrov A; Hermann FG; von Laer D; Baum C
Gene Ther; 2006 Jul; 13(13):1037-47. PubMed ID: 16541120
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors.
Tian C; Bagley J; Forman D; Iacomini J
Gene Ther; 2006 Apr; 13(7):652-8. PubMed ID: 16341058
[TBL] [Abstract][Full Text] [Related]
18. Insertional mutagenesis and clonal dominance: biological and statistical considerations.
Fehse B; Roeder I
Gene Ther; 2008 Jan; 15(2):143-53. PubMed ID: 17972922
[TBL] [Abstract][Full Text] [Related]
19. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation.
Mostoslavsky G; Kotton DN; Fabian AJ; Gray JT; Lee JS; Mulligan RC
Mol Ther; 2005 Jun; 11(6):932-40. PubMed ID: 15922964
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of oncoretrovirally transduced hematopoietic stem cells and correction through ex vivo expansion.
Bryder D; Björgvinsdóttir H; Sasaki Y; Jacobsen SE
J Gene Med; 2005 Feb; 7(2):137-44. PubMed ID: 15538726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
